FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Phosphate Injection
Status: Currently in Shortage
»Date first posted: 08/22/2017
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Revised 09/14/2017)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Phosphorus 15 mmol/mL, 5 mL, Sodium 20 mEq/5mL vials (NDC 63323-170-05) Backordered. Next release anticipated December 2017. Demand increase for the drug
Phosphorus 45 mmol/15 mL, Sodium 60 mEq/15 mL (NDC 63323-170-15) Backordered. Next release anticipated December 2017. Demand increase for the drug

Hospira, Inc. (Reverified 09/21/2017)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
3 mmol/mL, 15 mL vial (NDC 0409-7391-72) Estimated next delivery: Late August 2017. Estimated recovery: 2Q 2018 Shortage per manufacturer: Manufacturing delay Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English